| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_815ab1b26f945aeec66fbc63d5b157f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc8746969a0fe6d88617ce0719fb494c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15fa00edbc91263c7b97aeceafed2d79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_507e74787175c87dcd724f3d3c5774ea |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-163333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-28 |
| filingDate |
2008-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bb6d2c747402e42ef31438fa01823d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d0ad2946a16a7ddd231080ea6f26329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ffe5178c2282b3d2b317be788944ba7 |
| publicationDate |
2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009061412-A1 |
| titleOfInvention |
Methods for detecting or monitoring cancer using lpe as a marker |
| abstract |
A method of detecting a cancer, such as ovarian cancer, in a test subject including (a) determining the amount of a lysophosphatidyl ethanolamine in a sample of a bodily fluid taken from the test subject, and (b) comparing the amount of the lysophosphatidyl ethanolamine in the sample of the bodily fluid taken from the test subject to a range of amounts of the lysophosphatidyl ethanolamine found in samples of the bodily fluid taken from a group of normal subjects of the same species as the test subject and lacking the cancer, such as ovarian cancer, whereby a change in the amount of the lysophosphatidyl ethanolamine in the sample of the bodily fluid from the test subject indicates the presence of the cancer, such as ovarian cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012214821-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133736-B2 |
| priorityDate |
2007-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |